Opus Genetics
IRD · NASDAQ
$4.01+$0.19 (+4.97%)TodayMarket closed ·
Prev close $3.82
Who owns IRD
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 44.9% of IRD’s shares.
- Caligan Partners, LP7.4%
- Adage Capital Management, L.P.7.3%
- Foundation Fighting Blindness Inc4.6%
- Bios Equity Partners, LP.4.5%
- Next 6 largest institutions21.2%
- All other shareholders55.1%
| Holder | Shares | % of shares |
|---|---|---|
| Caligan Partners, LP | 6.08M | 7.36% |
| Adage Capital Management, L.P. | 6.03M | 7.30% |
| Foundation Fighting Blindness Inc | 3.79M | 4.59% |
| Bios Equity Partners, LP. | 3.68M | 4.46% |
| Balyasny Asset Management LP | 3.09M | 3.74% |
| Nantahala Capital Management, LLC | 3.06M | 3.71% |
| Vanguard Capital Management, LLC | 2.96M | 3.58% |
| BlackRock Institutional Trust Company, N.A. | 2.82M | 3.42% |
| Boxer Capital Management, LLC | 2.81M | 3.41% |
| Trails Edge Capital Partners LP | 2.74M | 3.32% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.24M | 2.71% |
| iShares Russell 2000 ETF | 1.34M | 1.63% |
| Vanguard Extended Market Index Fund | 652.28K | 0.79% |
| Fidelity Small Cap Index Fund | 580.92K | 0.70% |
| iShares Russell 2000 Growth ETF | 506.74K | 0.61% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $10.57M (13 trades) of IRD on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Sale | 556.00K | $2.76M |
| Magrath George | Option exercise | 392.16K | — |
| Magrath George | Tax withholding | 75.54K | $450.98K |
| Magrath George | Option exercise | 392.16K | $450.98K |
| Gallagher Cam | Option exercise | 784.31K | — |
| Gallagher Cam | Option exercise | 784.31K | $901.96K |
| Gagnon Robert E. | Sale | 28.00K | $127.21K |
| Magrath George | Sale | 9.47K | $27.93K |
| Gagnon Robert E. | Sale | 7.78K | $22.94K |
| SCHACHLE JOSEPH K | Sale | 4.64K | $13.65K |
Short interest
Settled Sep 30, 2026
- Shares short
- 13.01M
- Days to cover
- 6.05
- % of shares outstanding
- 15.76%
- Average daily volume
- 2.15M
- Change since last report
- +3.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.